Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Explore the significant impact of obesity on multiple sclerosis (MS) progression, including increased symptoms, disability, and comorbidities. Learn how to manage weight effectively with professional ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

Many women with multiple sclerosis (MS) notice a worsening of symptoms or progression just as menopause begins. While getting older is linked with disease progression in both men and women, hormones ...

Pediatric multiple sclerosis researchers at UB are working to define and better understand previously unappreciated and uncommon types of childhood demyelinating disorders, including MS, to improve ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...